Treatment of Severe Fibromyalgia Syndrome Associated to Functional Failure of Somatotropic Axis With Recombinant Growth Hormone. A Multicenter, Randomized, Double Blind, Placebo Controlled Study.

Trial Profile

Treatment of Severe Fibromyalgia Syndrome Associated to Functional Failure of Somatotropic Axis With Recombinant Growth Hormone. A Multicenter, Randomized, Double Blind, Placebo Controlled Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Somatropin (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Sponsors EMD Serono
  • Most Recent Events

    • 01 Jul 2012 Primary endpoint 'Tender-point-count' has been met.
    • 12 Dec 2011 Trial trial location (Spain) identified as reported by ClinicalTrials.gov.
    • 12 Dec 2011 Additional trial affiliate (Merck KGaA), location and actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top